Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Amgen

Stock Index Futures Muted Ahead of U.S. JOLTs Report and Fed Speak, Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

Barchart

Stock Index Futures Slip on Trade War Concerns, U.S. JOLTs Report and Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs.

Barchart

Are Wall Street Analysts Predicting Amgen Stock Will Climb or Sink?

Despite Amgen's underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Amgen’s Q4 2024 Earnings: What to Expect

Drug manufacturing giant Amgen is expected to announce its fourth-quarter results in the upcoming month and analysts expect single-digit growth in earnings.

Barchart

Build a Bulletproof Portfolio with These Three Diversified Dividend Stocks

Learn how diversification, careful screening, and key metrics like payout ratios and yields can help build a strong, income-generating portfolio for the long term.

Barchart

Selling Covered Calls On The Dogs Of The Dow Stocks

The Dogs of the Dow is a long standing wall street strategy for investing in the stock market that involves purchasing the 10 highest yielding Dow Jones stocks.

Barchart

Amgen Stock Falls on Weight Loss Drug Data: Overreaction or Fair?

Results for Amgen's weight loss drug Maritide were highly anticipated, but fell short. However, MariTide could still turn the tables in future studies.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Is Amgen Stock Underperforming the Dow?

Despite pharma giant Amgen trailing behind the Dow index over the past three months, analysts remain cautiously bullish about the stock's growth potential.

Barchart

3 Biotech Stocks with Promising Pipelines to Watch

As breakthroughs in biotechnology accelerate, the sector is primed for significant expansion. With emerging trends like gene editing and precision medicine transforming healthcare, fundamentally solid biotech stocks such as Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) are gaining traction. With promising innovations, these stocks could be prime investment opportunities.…

StockNews.com

Stock Market Today: The S&P 500 Reclaims the 6K Level

Investors see Scott Bessent as a safe shepherd of the economy as the president-elect burnishes his "Tariff Man" reputation.

Kiplinger

Stocks Gain on Positive Corporate News and a Jump in US Consumer Confidence

The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.59%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.45%. Stocks today are mixed, with some positive corporate news lifting the broader market. JM...

Barchart

Stocks Climb on Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.48%. Stocks today are mixed, with some positive corporate news lifting the broader market. JM...

Barchart

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

Amgen's Phase 2 MariTide trial showed ~20% weight loss at 52 weeks, cardiometabolic improvements, and no significant safety issues.

Benzinga

3 Top Healthcare Stocks to Buy for Growth and Dividends

Investors seeking growth and dividend income in the healthcare sector may want to consider Eli Lilly, Gilead Sciences, and Amgen, which have delivered impressive returns and boast strong pipelines and strategic moves.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is Amgen Stock Outperforming the Nasdaq?

Amgen has surpassed the Nasdaq recently, and analysts are cautiously optimistic about its future potential.

Barchart

AMGN Bullish Diagonal Trade Targets a Price of $350 by October 18th

A bullish diagonal spread is an advanced option trade and generally not suitable for beginners, but it can have its place within an option portfolio.

Barchart

Are Wall Street Analysts Bullish on Amgen Stock?

Amgen has outperformed the broader market over the past year, yet Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

What You Need to Know Ahead of Amgen's Earnings Release

Amgen is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit dip.

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger

The Future of Weight-Loss Drugs for Investors

Weight-loss drugs’ impact could reach far beyond their target user, potentially creating headwinds for shares of snack makers and packaged-food firms, as well as medical device makers that specialize in knee replacements, insulin pumps and sleep apnea machines.

International Business Times UK

Ark Invest CEO Cathie Wood Boosts Stake in Firms Making Breakthroughs in Gene Editing, AI Drug Development, and Obesity Drugs

Cathie Wood splurged millions in biotech this year on strong clinical progress, AI adoption, sales growth, wider outreach, and steady product pipelines.

StockNews.com

3 Biotech Stocks Poised for May Surges

The use of advanced technologies, growing demand for personalized medicines, and rising investments in R&D are boosting the biotech industry’s prospects. Given this backdrop, investors could consider buying quality biotech stocks: Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and ANI Pharmaceuticals (ANIP). Read on.

Barchart

Stocks Close Higher as the Outlook Improves for Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) Friday closed up +1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.99%. US stock indexes Friday settled moderately higher, with the S&P 500 and Nasdaq 100...

Kiplinger

Stock Market Today: Stocks Soar on Apple Buyback News, Jobs Data

The main indexes rallied hard to end the week thanks to Apple's $110 billion stock repurchase plan and a big April payrolls miss.

Barchart

Stocks Climb as US Jobs Report Ramps Up Fed Rate Cut Expectations

The S&P 500 Index ($SPX ) (SPY ) this morning is +0.86%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.81%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.65%. US stock indexes this morning are moderately higher, with the S&P 500 and Nasdaq...

Barchart

Stocks Jump on Apple Earnings and Dovish Apr Payroll Report

The S&P 500 Index ($SPX ) (SPY ) this morning is +1.00%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.59%. US stock indexes this morning are moderately higher, with the S&P 500 and Nasdaq...

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.